
Noopept vs. Piracetam: Peptide Marketing and Evidence-Based Pharmacology
Marketers have spent years selling the idea of a "domestic peptide that is 1,000 times stronger than piracetam." It sounds like a long-awaited technological breakthrough for boosting memory, yet behind the loud number lies ordinary manipulation of mouse dosages.
In a test tube, the molecule binds to its target at a microscopic dose, but the human digestive tract destroys peptides in minutes. Not a single authoritative placebo-controlled clinical trial has ever confirmed real benefits for cognition.






